查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566883

肠内注射器市场：按类型、年龄层和最终用户分类：2024-2033 年全球机会分析和产业预测

Enteral Syringe Market By Type (Reusable, Disposable), By Age Group (Adults, Pediatrics) By End User (Hospitals, Ambulatory Surgical Centers, Homecare) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 251 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球肠内注射器市值为3.836亿美元，预计2024年至2033年复合年增长率为5.3%，到2033年将达到6.436亿美元。

肠内注射器是一种专门的医疗设备，用于通常透过饲管将液体药物、营养素或液体直接注入胃肠道。此註射器经过专门设计，具有精确的体积测量、与经肠营养管相容以及防止意外断开和洩漏的安全功能等特性。

贫穷、营养食品取得不足、慢性病和人口老化推动了肠内注射器市场的成长，这些因素导致营养不良发生率上升。肠内注射器在将必需的营养物质直接输送到胃肠道方面发挥着重要作用，使患者在口服摄入不足或不可能时获得足够的营养。此外，居家医疗的成长趋势正在推动市场发展。随着越来越多的患者家用而不是在医院寻求肠内药物和营养支持，对易于使用的肠内注射器的需求正在增加。因此，製造商生产易于使用且与家用经肠营养设备相容的注射器。

然而，严格的政府监管限制了市场的成长。监管机构对包括肠内注射器在内的医疗设备实施严格的标准和核准流程，以确保安全性、有效性和品质。相比之下，副作用较少的先进经肠营养设备的开拓代表了市场成长的机会。肠内注射器设计、材料和功能的创新旨在提高患者舒适度、减少併发症并改善治疗结果。例如，百特国际公司开发的肠内注射器具有符合人体工学的设计、精确的剂量控制机制和抗逆流功能，可最大限度地降低误吸和导管相关併发症的风险，并使经肠营养更安全、更有效率。

细分概述

肠内注射器市场按类型、年龄层、最终用户和地区细分。根据类型，市场分为可重复使用型和一次性型。依年龄段，分为成人和儿童。按最终用户划分，可分为医院、门诊手术中心 (ASCS) 和居家医疗。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区进行了分析。

竞争场景

该报告可以定制。

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要参与者的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章耳鼻喉科注射器市场：依类型

  • 市场概况
  • 可重复使用的
  • 一次性的

第五章耳鼻喉科注射器市场：依年龄组

  • 市场概况
  • 成人
  • 小儿科

第六章 耳鼻喉科注射器市场：依最终使用者分类

  • 市场概况
  • 医院
  • 门诊手术中心
  • 居家医疗

第七章肠内注射器市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国肠内注射器市场
    • 加拿大肠内注射器市场
    • 墨西哥肠内注射器市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国肠内注射器市场
    • 法国肠内注射器市场
    • 英国肠内注射器市场
    • 义大利肠内注射器市场
    • 西班牙肠内注射器市场
    • 其他欧洲国家肠内注射器市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本肠道注射器市场
    • 中国肠内注射器市场
    • 印度肠内注射器市场
    • 澳洲肠内注射器市场
    • 韩国肠内注射器市场
    • 其他亚太肠内注射器市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西肠内注射器市场
    • 沙乌地阿拉伯肠内注射器市场
    • 南非肠内注射器市场
    • 其他拉丁美洲/中东/非洲肠内注射器市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Fresenius SE And Co. KGaA
  • Boston Scientific Corporation
  • Danone
  • Cook Medical, Inc.
  • Cardinal Health Inc.
  • Becton, Dickinson And Company
  • Moog Inc.
  • B. Braun Melsungen AG
  • Owens And Minor, Inc.
  • Nestle SA
简介目录
Product Code: A200746

The global enteral syringe market was valued at $383.6 million in 2023, and is projected to reach $643.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

An enteral syringe is a specialized medical device used for administering liquid medications, nutrients, or fluids directly into the gastrointestinal tract, typically through a feeding tube. This syringe is specifically designed with features such as accurate volume measurement, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage.

The growth of the enteral syringe market is driven by poverty, inadequate access to nutritious food, chronic illnesses, and aging populations contribute to the rising incidence of malnutrition cases. Enteral syringes play a crucial role in delivering essential nutrients directly into the gastrointestinal tract, ensuring patients receive adequate nutrition when oral intake is insufficient or not feasible. Moreover, rise in the trend toward home healthcare is driving the market forward. With the rise in the number of patients seeking enteral medication and nutrition at home rather than admitted to hospitals, the demand for user-friendly enteral syringes is growing. Thus, manufacturers are producing syringes that are easy to use and set compatible with home enteral feeding equipment.

However, stringent governmental regulations pose a restraint to the growth of the market growth. Regulatory authorities impose strict standards and approval processes for medical devices, including enteral syringes, to ensure safety, efficacy, and quality. Contrarily, the development of advanced feeding devices with lesser side effects presents an opportunity for the growth of the market. Innovations in enteral syringe design, materials, and functionalities aim to enhance patient comfort, reduce complications, and improve treatment outcomes. For instance, the development of enteral syringes, by Baxter International Inc., with ergonomic designs, precise dosage control mechanisms, and anti-reflux features can minimize the risk of aspiration and tube-related complications, making enteral feeding safer and more efficient.

Segmentation Overview

The enteral syringe market is segmented into type, age group, end user, and region. Depending on the type, the market is bifurcated into reusable and disposable. According to age group, it is divided into adults and pediatrics. According to end user, the market is classified into hospitals, ambulatory surgical centers (ASCS), and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Scenario

The major players operating in the enteral syringe market include Fresenius SE & Co. KGaA, Boston Scientific Corporation, Danone, Cook Medical, Inc., Cardinal Health Inc., Becton, Dickinson and Company, Moog Inc., B. Braun Melsungen AG, Owens & Minor, Inc., and Nestle S.A. Other players in the enteral syringe market include Medtronic PLC, Medline Industries LP, Kentec Medical Inc., Thermo Fisher Scientific Inc, and Baxter International Inc. These players have employed several strategies such as mergers & acquisitions, partnerships, collaboration, and continuous product development and innovation to strengthen their position in the competitive environment.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

  • Reusable
  • Disposable

By Age Group

  • Adults
  • Pediatrics

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Fresenius SE & Co. KGaA
    • Boston Scientific Corporation
    • Danone
    • Cook Medical, Inc.
    • Cardinal Health Inc.
    • Becton, Dickinson and Company
    • Moog Inc.
    • B. Braun Melsungen AG
    • Owens & Minor, Inc.
    • Nestle S.A.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: ENTERAL SYRINGE MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Reusable
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Disposable
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ENTERAL SYRINGE MARKET, BY AGE GROUP

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Age Group
  • 5.2. Adults
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Pediatrics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ENTERAL SYRINGE MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Homecare
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ENTERAL SYRINGE MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Age Group
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Enteral Syringe Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Age Group
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Enteral Syringe Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Age Group
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Enteral Syringe Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Age Group
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Age Group
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Enteral Syringe Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Age Group
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Enteral Syringe Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Age Group
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Enteral Syringe Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Age Group
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Enteral Syringe Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Age Group
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Enteral Syringe Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Age Group
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Enteral Syringe Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Age Group
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Age Group
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Enteral Syringe Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Age Group
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Enteral Syringe Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Age Group
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Enteral Syringe Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Age Group
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Enteral Syringe Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Age Group
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Enteral Syringe Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Age Group
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Enteral Syringe Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Age Group
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Age Group
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Enteral Syringe Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Age Group
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Enteral Syringe Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Age Group
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Enteral Syringe Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Age Group
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Enteral Syringe Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Age Group
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Fresenius SE And Co. KGaA
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Danone
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Cook Medical, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Cardinal Health Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Becton, Dickinson And Company
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Moog Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. B. Braun Melsungen AG
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Owens And Minor, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Nestle S.A.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments